Gideon E. Bollag
Gründer bei Opna Bio SA
Ursprung des Netzwerks ersten Grades von Gideon E. Bollag
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA.
10
| Subsidiary | Miscellaneous Commercial Services | 10 |
Opna Bio SA
 Opna Bio SA Pharmaceuticals: GenericHealth Technology Opna Bio is a clinical-stage biopharmaceutical company located in the US that focuses on discovering and developing novel oncology therapeutics. Opna's lead clinical compound, opn-2853, a bromo and extra terminal (bet) domain inhibitor, is currently in a phase 1/2 trial with ruxolitinib (jakafi®) in myelofibrosis, a chronic bone marrow disorder. The American company's team has a proven track record of scientific expertise and commercial value creation, having advanced multiple FDA-approved drugs to market. The company has a broad portfolio that targets multiple drivers of cancer, including a novel oncology discovery program focused on the fragile-x mental retardation protein (fmrp) and a diversified pipeline of validated oncology assets acquired from plexxikon.
1
| Holding Company | Pharmaceuticals: Generic | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Gideon E. Bollag
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| CARDINAL HEALTH, INC. | Medical Distributors | Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| IBM | Packaged Software | Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Director/Board Member | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| INTERMUNE INC | Biotechnology | Chief Operating Officer Corporate Officer/Principal | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director of Finance/CFO | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Afferent Pharmaceuticals, Inc.
 Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afferent Pharmaceuticals, Inc. develops selective drugs for the treatment of debilitating neurogenic disorders. It offers programs for respiratory, cardiovascular, chronic pain, biology, and clinical trials. The firm offers drugs for osteoarthritis pain, treatment-refractory chronic cough, and interstitial cystitis or bladder pain syndrome. The company was founded by Anthony P. Ford in December 2009 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
CellGate Technologies LLC
 CellGate Technologies LLC Computer PeripheralsElectronic Technology Part of StarVox Communications, Inc., CellGate Technologies LLC is a company that manufactures integrated wireless IP modem adapters and provides wireless services. The company is based in Boca Raton, FL. The company was founded by Edgar G. Engleman. CellGate Technologies was acquired by U.S. Wireless Data, Inc. on November 17, 2000 for $2.23 million. | Computer Peripherals | Corporate Officer/Principal | |
| Vanderbilt University | College/University | Doctorate Degree | |
Roche Palo Alto LLC
 Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Yale University | College/University | Graduate Degree | |
| New York University | College/University | Undergraduate Degree | |
| Stockton University | College/University | Undergraduate Degree | |
| University of Florida | College/University | Doctorate Degree | |
| University of Louisville | College/University | Doctorate Degree | |
Rinat Neuroscience Corp.
 Rinat Neuroscience Corp. BiotechnologyHealth Technology Rinat Neuroscience Corp. manufactures and markets drugs for treating neurological diseases. The company was founded by Arnon Rosenthal and Patrick G. Lynn on November 21, 2000 and is headquartered in South San Francisco, CA. | Biotechnology | Director of Finance/CFO | |
CytomX Therapeutics Holdings LLC
 CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Haas School of Business | College/University | Undergraduate Degree | |
| KITE PHARMA INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
Syapse, Inc.
 Syapse, Inc. Packaged SoftwareTechnology Services Syapse, Inc. develops software solutions that enable healthcare providers to deploy precision medicine programs. Its medical platform is used to integrate complex genomic and clinical data to provide clinicians with actionable insights at point of care, enabling diagnosis, treatment, and outcomes tracking. The firm offers a suite of clinical applications built on the Syapse Precision Medicine Platform and designed to help healthcare providers implement and scale precision medicine at the point of care. The company was founded by Tony Loeser, Glenn S. Winokur, and Jonathan Hirsch in 2008 and is headquartered in San Francisco, CA. | Packaged Software | Director of Finance/CFO | |
| Vanderbilt University School of Medicine | College/University | Doctorate Degree | |
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Chairman Director/Board Member | |
Arbor Biotechnologies, Inc.
 Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
CuraSen Therapeutics, Inc.
 CuraSen Therapeutics, Inc. BiotechnologyHealth Technology CuraSen Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapies to treat neurodegenerative diseases, including parkinson, alzheimer, and less common neurodegenerative disorders. The company was founded by Mehrdad Shamloo, Robert Booth, Anthony Ford, and Kathleen Sereda in 2018 and is headquartered in San Mateo, CA. | Biotechnology | Founder | |
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Chairman | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KYVERNA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ALX ONCOLOGY HOLDINGS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Totus Medicines, Inc.
 Totus Medicines, Inc. Pharmaceuticals: MajorHealth Technology Totus Medicines, Inc. manufactures drug products. The company is based in Cambridge, MA. The company was founded by Neil Dhawan, Jason Pontin. Neil Dhawan has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Garuda Therapeutics, Inc.
 Garuda Therapeutics, Inc. BiotechnologyHealth Technology Garuda Therapeutics, Inc. aims to eliminate the need for donor or patient cells for blood stem cell transplants. The company is based in Natick, MA. The company's platform technology generates off-the-shelf, self-renewing blood stem cells that are HLA-compatible and transgene-free. This technology could potentially provide curative therapies for over 120 diseases. Garuda Therapeutics was founded by Dhvanit Shah, Sean Morrison, and David T. Scadden, with Dhvanit Shah serving as CEO since incorporation. | Biotechnology | Director/Board Member | |
| IO BIOTECH, INC. | Biotechnology | Chairman Director/Board Member | |
Incendia Therapeutics, Inc.
 Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Incendia Therapeutics, Inc. develops a novel class of anti-cancer therapies. The company is based in Boston, MA. The company was founded in 2003 by Laurent Audoly, Colin Glenn Begley, Olga Granaturova, Guy Travis Clifton. Laurent Audoly has been the CEO since 2003. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 46 |
| Dänemark | 3 |
| Kanada | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 36 |
| Consumer Services | 10 |
| Technology Services | 3 |
| Electronic Technology | 3 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 41 |
| Corporate Officer/Principal | 28 |
| Director of Finance/CFO | 12 |
| Chief Tech/Sci/R&D Officer | 12 |
| Independent Dir/Board Member | 8 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jean Deleage | 23 |
| K. Hirth | 18 |
| C. Payne | 14 |
| Kathleen Glaub | 13 |
| Thomas Kassberg | 12 |
| Steve Liapis | 11 |
| Glenn Michelson | 9 |
| Gary C. Visor | 9 |
| Keith B. Nolop | 5 |
| Athanasios Tsiatis | 4 |
| Marguerite Hutchinson | 1 |
- Börse
- Insiders
- Gideon E. Bollag
- Unternehmensverbindungen
